Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 12826316)

Published in Lung Cancer on July 01, 2003

Authors

Paola Mazzanti1, Cristian Massacesi, Marco B L Rocchi, Rodolfo Mattioli, Paolo Lippe, Raffaele Trivisonne, Franco Buzzi, Giorgio De Signoribus, Guido Tuveri, Giorgio Rossi, Liberato Di Lullo, Fabio Sturba, Donatella Morale, Sergio Catanzani, Alberta Pilone, Maurizio Bonsignori, Tullio Battelli

Author Affiliations

1: Department of Medical Oncology, Azienda Ospedaliera Umberto I, via Conca, 60122 Torrette di Ancona, Italy. p.mazzanti@ao-umbertoprimo.marche.it

Articles by these authors

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol (2005) 3.19

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol (2009) 2.80

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol (2005) 2.11

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy. J Clin Oncol (2007) 2.08

Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry (2012) 1.99

A new real-time PCR method to overcome significant quantitative inaccuracy due to slight amplification inhibition. BMC Bioinformatics (2008) 1.72

Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res (2003) 1.61

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial. J Clin Oncol (2012) 1.55

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. Dig Liver Dis (2010) 1.54

Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumab. J Clin Oncol (2010) 1.52

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood (2002) 1.50

Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study. Oncology (2011) 1.48

Feasibility and limits of split liver transplantation from pediatric donors: an italian multicenter experience. Ann Surg (2006) 1.43

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. Invest New Drugs (2014) 1.23

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy. Cancer (2006) 1.16

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer. Breast Cancer Res Treat (2010) 1.13

Attitudes of Italian liver transplantation centers toward the eligibility of controversial candidates. Liver Transpl (2014) 1.07

Some practical considerations for phase III studies with biomarker evaluations. J Clin Oncol (2014) 1.07

Phase Ib study of Buparlisib plus Trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on Trastuzumab-based therapy. Clin Cancer Res (2014) 1.06

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia. Dig Dis Sci (2011) 1.06

Does dance-based training improve balance in adult and young old subjects? A pilot randomized controlled trial. Aging Clin Exp Res (2005) 1.06

Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04

Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. J Hepatol (2008) 1.03

Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. Cancer (2007) 1.02

Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol (2008) 1.01

Primary pleural epithelioid angiosarcoma. A case report and review of the literature. Pathol Res Pract (2010) 0.99

Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med (2007) 0.96

Relationship between migraine and epilepsy in pediatric age. Headache (2006) 0.93

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer. Cancer (2007) 0.93

Shape based kinetic outlier detection in real-time PCR. BMC Bioinformatics (2010) 0.93

Static magnetic fields affect cell size, shape, orientation, and membrane surface of human glioblastoma cells, as demonstrated by electron, optic, and atomic force microscopy. Cytometry A (2006) 0.93

Ultrastructural morphometrical and immunocytochemical analyses of hepatocyte nuclei from mice fed on genetically modified soybean. Cell Struct Funct (2002) 0.92

Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study. Acta Oncol (2011) 0.91

Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis. Neurol Sci (2015) 0.91

Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers (2009) 0.90

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. Lung Cancer (2010) 0.88

Emerging treatment strategies in Tourette syndrome: what's in the pipeline? Int Rev Neurobiol (2013) 0.88

Psychopathology in children and adolescents with Tourette's syndrome: a controlled study. Brain Dev (2005) 0.88

Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One (2011) 0.88

Desmoplastic small round cell tumour: a description of two cases and review of the literature. Oncology (2003) 0.87

The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone. Cancer Invest (2003) 0.86

Long-term follow-up of an adolescent who had bilateral striatal necrosis secondary to Mycoplasma pneumoniae infection. Brain Dev (2005) 0.86

A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival. J Clin Gastroenterol (2005) 0.85

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study. Med Oncol (2004) 0.85

Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy. Oncol Rep (2003) 0.85

Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncol (2013) 0.85

Shades of vulnerability: latent structures of clinical caseness in prodromal and early phases of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84

Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum (2007) 0.84

Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int (2005) 0.83

Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer. Oncology (2006) 0.83

Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. J Hepatol (2008) 0.83

Changes in the seasonality of suicides over time in Slovenia, 1971 to 2002. J Affect Disord (2006) 0.83

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. Oncol Rep (2006) 0.83

Prevalence of self-reported childhood abuse in psychosis: a meta-analysis of retrospective studies. Psychiatry Res (2013) 0.83

Ultrastructural analysis of pancreatic acinar cells from mice fed on genetically modified soybean. J Anat (2002) 0.82

Preoccupation and distress are relevant dimensions in delusional beliefs. Compr Psychiatry (2012) 0.82

Use of multiparameter analysis for Vibrio alginolyticus viable but nonculturable state determination. Cytometry A (2006) 0.82

External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a phase II study. Int J Radiat Oncol Biol Phys (2009) 0.82

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients. Crit Rev Oncol Hematol (2008) 0.81

Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review. Tumori (2012) 0.81

Changes in the seasonality of suicides over time in Slovenia, 1971 to 2002. Amplitude is only positively related to suicide rates among females. J Affect Disord (2007) 0.81

Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma. Obstet Gynecol (2009) 0.81

The epidemiology of homicide in Italy by season, day of the week and time of day. Med Sci Law (2011) 0.81

Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer. Int J Radiat Oncol Biol Phys (2010) 0.81

Combined liver-kidney transplantation in glycogen storage disease Ia: a case beyond the guidelines. Liver Transpl (2007) 0.81

Symptoms of psychosis in anorexia and bulimia nervosa. Psychiatry Res (2009) 0.81

Physiologic responses of firefighter recruits during a supervised live-fire work performance test. J Strength Cond Res (2009) 0.80

Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection. Transplantation (2007) 0.80

The psychometric discriminative properties of the Peters et al Delusions Inventory: a receiver operating characteristic curve analysis. Compr Psychiatry (2006) 0.79

Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy. Liver Transpl (2012) 0.79

Autism and classification systems: a study of 84 children. Ital J Pediatr (2010) 0.79

Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer. Tumori (2012) 0.79

Simultaneous characterization of progenitor cell compartments in adult human liver. Cytometry A (2010) 0.79

Metabolic syndrome after liver transplantation: short-term prevalence and pre- and post-operative risk factors. Dig Liver Dis (2013) 0.78

Apoptotic DNA fragmentation can be revealed in situ: an ultrastructural approach. Microsc Res Tech (2009) 0.78

Automated analysis of morphometric parameters for accurate definition of erythrocyte cell shape. Cytometry A (2003) 0.78

A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study. Ann Surg (2014) 0.78

The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy. Crit Rev Oncol Hematol (2010) 0.78

Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors. Anticancer Drugs (2003) 0.78

Accurate and precise DNA quantification in the presence of different amplification efficiencies using an improved Cy0 method. PLoS One (2013) 0.78

Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? Liver Transpl (2015) 0.78

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients. Alcohol Alcohol (2004) 0.78

Diagnostic boundaries of autism disorder vs pervasive developmental disorder nos comparative observational study and literature review. Curr Clin Pharmacol (2014) 0.78

Dose-finding trial of a combined regimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An Italian Oncology Group for Clinical Research (GOIRC) study. J Immunother (2010) 0.77

Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men. PLoS One (2013) 0.77

Alteration in the transcriptional profile of livers from brain-dead organ donors. Transplantation (2006) 0.77

Drug attitude in adolescents: a key factor for a comprehensive assessment. J Clin Psychopharmacol (2014) 0.77